Novartis | NVS - Zobowiązania





Zobowiązania Zmiana Data
AbbVie USD 41.64B 458M 2026-06
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Bausch Health Companies USD 4.75B 205M 2026-09
Biogen USD 3.9B 18.7M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Canopy Growth CAD 166.75M 8.31M 2026-06
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Drreddys Laboratories INR 154.49B 13.08B 2026-09
Eli Lilly USD 47B 745M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Glaxosmithkline GBP 20.72B 1.71B 2026-09
J&J USD 55.46B 562M 2026-09
Merck USD 27.73B 786M 2026-06
Novartis USD 32.52B 777M 2026-09
Novartis USD 32.52B 1.15B 2026-09
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 31.73B 920M 2026-09
Phibro Animal Health USD 316.47M 34.6M 2026-06
Prestige Brands USD 153.81M 32.88M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
Sanofi EUR 31.93B 1.92B 2026-06
Supernus Pharmaceuticals USD 285.4M 61.98M 2026-09
Zoetis USD 2.06B 8M 2026-06